Regulatory Guidance

How did the FDA do in 2019? Tell us what you think!

Take our ultra quick survey for a chance to be quoted in our December issue.

As always, the FDA tackled major challenges in 2019 — from streamlining drug approvals to promoting data integrity, combatting drug shortages, fighting the opioid epidemic and more. How well did the agency fare? 

Our December cover story will take a close look at some of the biggest regulatory issues of 2019. But we also want your take on what the FDA got right — and where it needs to improve.

Take our quick two-question survey and give us your thoughts on the FDA’s biggest wins and fails of 2019 for a chance to get quoted in our December issue. Current survey results from other readers will be available instantly after you click “Submit” — and final results will appear in our December issue.


Free Subscriptions

Pharma Manufacturing Digital Edition

Access the entire print issue on-line and be notified each month via e-mail when your new issue is ready for you. Subscribe Today. E-Newsletters

A mix of feature articles and current new stories that are critical to staying up-to-date on the industry, delivered to your inbox. Choose from an assortment of different topics and frequencies. Subscribe Today.